Category: Research/Reports

AHA Report: 340B Hospitals Face More Federal Oversight, Fare Better in Audits; HRSA Releases Latest Drugmaker Audit

June 20, 2025 Shannon Young, Associate Editor/Senior Writer Views

A new AHA analysis found that 340B hospitals face more federal oversight and routinely see higher rates of compliance in federal audits than drugmakers.

Hospitals that participate in the 340B program face more federal oversight and routinely see higher rates of compliance in federal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Drug-Industry Funded Study Finds Utilization Drives 340B Program Growth, Not Rising Drug Prices

June 10, 2025 Bella Czajkowski, National Correspondent Views

A recent drug-industry funded study in Health Affairs Scholar found that increased utilization, rather than rising drug prices, drives 340B program growth.

A recent drug-industry-funded study attributes the 340B program’s recent growth to increased utilization—not rising drug prices. The May 21 study, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Hospital Group-Funded Working Paper Calls for Increased 340B Visibility Among Economists

June 5, 2025 Bella Czajkowski, National Correspondent Views

A recent working paper called for more economists to study the 340B program, which could broaden policymakers' understanding of its impact.

There’s a gap in economics research on the 340B program, and economists could enrich 340B stakeholders’ understanding of the program [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Drug Industry-Funded White Paper Ties 340B to Rising Commercial Insurance Premiums; Provider Advocates Criticize Study

May 15, 2025 Bella Czajkowski, National Correspondent Views

A recent drug industry-funded white paper drew a connection between 340B and increases in commercial insurance premiums, but provider advocates and attorneys criticized its methodology and findings.

The 340B program is driving up employer-sponsored health insurance premiums, according to a drug industry-funded white paper. Provider advocates criticized [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Trump-Aligned Think Tank Proposes Lowering U.S. Drug Prices Through IRA and Other Policies, Doesn’t Weigh In on 340B Program

March 27, 2025 Shannon Young, Associate Editor/Senior Writer Views

America First Policy Institute released a March 21 brief detailing how policymakers “could accelerate drug development and enhance patient health by implementing reforms that discourage other countries from freeloading off American drug innovation.”

A conservative think tank, which officials who served in President Donald Trump’s (R) first administration founded to advance his priorities, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Misinformation Makes Up Small Part of 340B Conversations Online, But Garners Outsized Attention, Analysis Finds

March 11, 2025 Shannon Young, Associate Editor/Senior Writer Views

Storyful Rx analyzed more than 6,000 social media posts and articles mentioning the 340B program between Aug. 11, 2024 and Feb. 11, 2025.

Although misinformation accounts for just 2% of the overall 340B conversations taking place online, “conspiratorial narratives” driven by conservative influencers—and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Drug Industry-Funded Study Finds 340B Contract Pharmacy Bills Costly to Employer Health Plans and States; Critics Slam Its Methodology and Funding Source

February 21, 2025 Shannon Young, Associate Editor/Senior Writer Views

IQVIA examined how state 340B contract pharmacy access bills could affect state and local governments in a Feb. 4 white paper funded by the National Pharmaceutical Council.

340B contract pharmacy access bills could cost states millions and employer health plans more, according to a new study funded [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Study Finds 340B Providers Prescribe More Often Without Increasing Survival Rate of Breast Cancer; Hospital Advocate Challenges Conclusion

February 13, 2025 Bella Czajkowski, National Correspondent Views

The Feb. 3 study compared 340B versus non-340B provider prescribing patterns for breast cancer patients.

A recent study suggested that 340B providers prescribe more drugs for treating breast cancer, but do not have any significant [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Program Had No Impact on Prostate Cancer Care, Study Suggests

January 16, 2025 Bella Czajkowski, National Correspondent Views

A study in the academic journal Cancer Medicine examined the relationship between the 340B program and prostate cancer care.

Participation in the 340B program did not increase the number of vulnerable patients beginning targeted care for prostate cancer, a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Minnesota Issues 1st State Report on 340B, Critics Say it ‘Misses Critical Context’

November 26, 2024 Shannon Young, Associate Editor/Senior Writer Views

The Minnesota Department of Health on Monday unveiled the findings of its first legislatively required 340B Covered Entity Report.

Minnesota providers, namely the state’s largest 340B hospitals, generated hundreds of millions of dollars in collective net revenue from the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Staff Email

Site Footer Live